Data / New clinical trials / Influenza, Human

Influenza, Human trials: 168 new since Nov 2024

Name: New Influenza, Human clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Influenza, Human clinical trials: 168 rows for $8.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 11 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/influenza-human, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

168 clinical studies in Influenza, Human were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 61 have an industry sponsor and 103 are recruiting or about to. The newest, NCT07926217, was posted on November 9, 2026: High-Dose Versus Standard-Dose Influenza Vaccine in Patients With Hematologic Malignancies Receiving... (Sung-Han Kim).

The request: Every new Influenza, Human clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

168New trials
61Industry sponsored
103Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 168, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926217	High-Dose Versus Standard-Dose Influenza Vaccine in Patients With Hematologic Malignancies Receiving B-Cell-Depleting Therapy	Sung-Han Kim	Phase 2	Recruiting	Hematologic Malignancy, Influenza	60	South Korea	clinicaltrials.gov
November 3, 2026	NCT07914673	Age-Associated Differences in Germinal Center Responses to Influenza and Rabies Vaccination in Humans	Washington University School of Medicine	Phase 4	Recruiting	Healthy Adult Participants, Age 65 and Older, Age 18 to 40, Immunology	40	United States	clinicaltrials.gov
November 2, 2026	NCT07910266	Impact of Egg-Based and Cell-Based Vaccine Platforms on Immune Responses to Repeated Influenza Vaccination	University of Missouri-Columbia	Phase 4	Recruiting	Immunology	220	United States	clinicaltrials.gov
October 28, 2026	NCT07901673	Information-Based Interventions for Influenza Vaccination Among Older Adults With Diabetes in Yangzhou, China	Southeast University, China	Not applicable	Completed	Diabetes Mellitus, Type 2, Influenza	759	China	clinicaltrials.gov
October 27, 2026	NCT07896850	Conversational AI for Adult Flu Vaccination Decisions	Calypta Systems, Inc.	Not applicable	Active not recruiting	Influenza, Human, Vaccine Hesitancy	220	United States	clinicaltrials.gov
October 26, 2026	NCT07893847	Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza	Capital Medical University	Phase 2/3	Not yet recruiting	Influenza, Human	570	China	clinicaltrials.gov
October 23, 2026	NCT07892872	Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections	Capital Medical University	Not applicable	Not yet recruiting	Respiratory Viral Infections, Influenza, SARS CoV 2 Infection	618	China	clinicaltrials.gov
October 22, 2026	NCT07890454	Study of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant in Adult...	Sanofi	Phase 3	Not yet recruiting	Immunization, Healthy Volunteers, COVID-19 Immunization, Influenza Immunization	6,000		clinicaltrials.gov
October 21, 2026	NCT07885540	Preoperative Pneumococcal and Influenza Vaccination to Prevent Postoperative Pulmonary Infection in Patients Undergoing Lung Resection for...	The First Affiliated Hospital of Guangzhou Medical University	Phase 4	Not yet recruiting	Pneumococcal Polysaccharide Vaccine, Influenza Vaccines, Preoperative, Lung Resection Surgery, Thoracic Surgery	1,278		clinicaltrials.gov
October 20, 2026	NCT07884175	A Study of Updated mRNA Seasonal Influenza Vaccines	ModernaTX, Inc.	Phase 4	Not yet recruiting	Seasonal Influenza	200		clinicaltrials.gov
October 20, 2026	NCT07883928	Phase 2/3 Clinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or Older	GC Biopharma Corp	Phase 2/3	Not yet recruiting	Influenza A, Influenza B, Influenza Vaccination	1,806	South Korea	clinicaltrials.gov
October 20, 2026	NCT07883421	Immunogenicity of Standard-Dose Versus High-Dose Influenza Vaccines in Older Adults in Singapore	Tan Tock Seng Hospital	Phase 4	Not yet recruiting	Influenza	150	Singapore	clinicaltrials.gov
October 20, 2026	NCT07882186	Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the...	Assistance Publique - Hôpitaux de Paris	Observational	Not yet recruiting	Vaccination Coverage Among Pregnant Women	1,605	France	clinicaltrials.gov
October 19, 2026	NCT07880158	Sequential Digital Intervention to Increase Influenza Vaccination in Patients With Heart Failure	Heart Health Research Center	Not applicable	Not yet recruiting	Heart Failure, Influenza Vaccination	588	China	clinicaltrials.gov
October 14, 2026	NCT07873671	A Trial of RLX-2508-102 in Healthy Volunteers	Atridia Pty Ltd.	Early phase 1	Not yet recruiting	Influenza	101	Australia	clinicaltrials.gov
October 14, 2026	NCT07873255	Artificial Intelligence-assisted Primary Care for Influenza Vaccination Among Chronic Patients in China (AIPC-Flu)	Fudan University	Not applicable	Not yet recruiting	Influenza Vaccination	1,300		clinicaltrials.gov
October 13, 2026	NCT07871448	Flu COVID Vaccine Views	George Washington University	Observational	Not yet recruiting	Influenza, COVID-19, Vaccination Willingness	550	United States	clinicaltrials.gov
October 13, 2026	NCT07870330	A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children	ModernaTX, Inc.	Phase 1	Recruiting	Seasonal Influenza	96	United States	clinicaltrials.gov
October 8, 2026	NCT07864597	Family Physician Nudges for Influenza Vaccination Among Older Adults	Fudan University	Not applicable	Not yet recruiting	Influenza Vaccination	3,060		clinicaltrials.gov
October 6, 2026	NCT07861854	Mucosal and Systemic Immunity Correlates of Protection Against Influenza in Young Children, Aged 2-5 Years (MUSIC-Flu)	National Institute for Communicable Diseases, South Africa	Observational	Recruiting	Influenza -Like Illness, Influenza (Healthy Volunteers)	150	South Africa	clinicaltrials.gov
October 2, 2026	NCT07854392	A Study to Evaluate the Immune Responses of Subunit Influenza Vaccine in Healthy Adults	Ab&B Bio-tech Co., Ltd.JS	Phase 4	Active not recruiting	Influenza	138	China	clinicaltrials.gov
October 1, 2026	NCT07851246	A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age	GlaxoSmithKline	Phase 3	Recruiting	Influenza, Human	3,000	United States	clinicaltrials.gov
September 29, 2026	NCT07846423	Abbott ID NOW Point-of-Care Testing	China Medical University Hospital	Not applicable	Recruiting	Influenza, Influenza-like Illness	1,080	Taiwan	clinicaltrials.gov
September 24, 2026	NCT07838298	Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults	Korea University Guro Hospital	Phase 4	Recruiting	Influenza Vaccination, Older Adults (65 Years and Older), Immunosenescence, Immunogenicity, Repeated Vaccination	180	South Korea	clinicaltrials.gov
September 21, 2026	NCT07832201	A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)	Sinovac Biotech Co., Ltd	Phase 4	Not yet recruiting	Influenza	150	China	clinicaltrials.gov
September 18, 2026	NCT07827599	A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in...	Hoffmann-La Roche	Phase 3	Recruiting	Influenza, Human, Respiratory Tract Infections, Post-exposure Prophylaxis	325	China	clinicaltrials.gov
September 11, 2026	NCT07816471	RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults	Hospital Italiano de Buenos Aires	Observational	Active not recruiting	Respiratory Syncytial Virus Infections, Immunocompromised Host, Influenza, COVID - 19	350		clinicaltrials.gov
September 11, 2026	NCT07814495	A Human Influenza Transmission Study Using Naturally Infected Community Donors	Emory University	Not applicable	Not yet recruiting	Influenza	150	United States	clinicaltrials.gov
September 4, 2026	NCT07805837	Comparative Immunologic Mechanisms and Microbiome Interactions Following Different Influenza Vaccine Formulations in Older Adults	Korea University Guro Hospital	Phase 4	Completed	Influenza, Influenza Vaccines, Microbiome, Immune Response	121	South Korea	clinicaltrials.gov
September 4, 2026	NCT07805707	A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age	GlaxoSmithKline	Phase 3	Recruiting	Influenza, Human	54,000	United States	clinicaltrials.gov
September 2, 2026	NCT07798882	Rule-Based High-Risk Flu	Geisinger Clinic	Not applicable	Completed	Influenza, Vaccination, Risk Reduction, Health Behavior, Health Promotion	51,218	United States	clinicaltrials.gov
September 1, 2026	NCT07798193	A Study of SYH2085 Tablets Compared With Placebo in Chinese Adult Patients With Uncomplicated Influenza.	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	Phase 2	Not yet recruiting	Influenza	213		clinicaltrials.gov
August 27, 2026	NCT07790523	Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 Years	Tor Biering-Sørensen	Phase 4	Not yet recruiting	COVID-19, Influenza	410,000	Denmark, Spain	clinicaltrials.gov
August 26, 2026	NCT07786662	Early Corticosteroids in Severe Influenza Pneumonia	Centre Hospitalier Régional Metz-Thionville	Phase 3	Not yet recruiting	Severe Influenza, Intensive Care (ICU), Reanimation, Infectious Diseases, Hygiene	544	France	clinicaltrials.gov
August 26, 2026	NCT07786467	Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations	Lake Erie College of Osteopathic Medicine	Not applicable	Recruiting	No Disease or Condition is Being Directly Studied, The Focus of the Study in Healthy Volunteers	50	United States	clinicaltrials.gov
August 21, 2026	NCT07779408	Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in...	Sanofi	Phase 1/2	Recruiting	Healthy Volunteers, Influenza	640	United States	clinicaltrials.gov
August 17, 2026	NCT07767019	Climate Change Trends and Their Impact on the Seasonal Upper Respiratory Tract Disease Burden	Barzilai Medical Center	Observational	Not yet recruiting	Upper Resp Tract Infection	5,000	Israel	clinicaltrials.gov
July 31, 2026	NCT07739719	SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluster Randomized Trial)	McMaster University	Phase 4	Not yet recruiting	Influenza (Healthy Volunteers)	966	Canada	clinicaltrials.gov
July 31, 2026	NCT07739446	Effect of Surgical Masks in Preventing Acute Respiratory Infections	Chiba University	Not applicable	Enrolling by invitation	Acute Respiratory Infections (ARIs), Influenza, COVID - 19	2,400	Japan	clinicaltrials.gov
July 30, 2026	NCT07737106	Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)	Sinovac Biotech Co., Ltd	Phase 1	Completed	Influenza	50	China	clinicaltrials.gov
July 24, 2026	NCT07726862	How Healthy Adults Respond to the Nasal Flu Vaccine	University of Alabama at Birmingham	Phase 4	Not yet recruiting	Mucosal Immune Response to Influenza Vaccination	20	United States	clinicaltrials.gov
July 23, 2026	NCT07721649	Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP)	Stephan Baldus	Not applicable	Recruiting	Acute Coronary Syndrome, Heart Failure, Influenza, Human, Cardiovascular Diseases, Vaccination Refusal	482	Germany	clinicaltrials.gov
July 17, 2026	NCT07710586	Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China	Ab&B Bio-tech Co., Ltd.JS	Phase 4	Completed	Influenza Vaccine	3,105	China	clinicaltrials.gov
July 14, 2026	NCT07703514	Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Not yet recruiting	Influenza	60	United States	clinicaltrials.gov
July 1, 2026	NCT07678619	Smart Analysis and Decision-Making for Emerging Infectious Diseases	Peking University	Not applicable	Enrolling by invitation	Emerging Infectious Diseases, COVID-19, Influenza, Mpox (Monkeypox), Dengue Fever, Chikungunya Fever, Avian Influenza	108	China	clinicaltrials.gov
June 29, 2026	NCT07673250	Personalized Ventilator Settings for Patients on ECMO	University of California, San Diego	Not applicable	Enrolling by invitation	Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation, Respiratory Failure Patients Treated...	62	United States	clinicaltrials.gov
June 16, 2026	NCT07651761	Patient-Centered Practical Vaccine Talk For Busy Clinicians	University of Massachusetts, Worcester	Not applicable	Enrolling by invitation	Influenza, COVID-19	24,500	United States	clinicaltrials.gov
June 12, 2026	NCT07645534	Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90...	Valenta Pharm JSC	Phase 1	Recruiting	Influenza, Acute Respiratory Viral Infections	36	Russia	clinicaltrials.gov
June 12, 2026	NCT07644546	Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical Trial	National Taiwan University Hospital	Not applicable	Not yet recruiting	HIV	350		clinicaltrials.gov
June 11, 2026	NCT07643688	Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections	Fabiana Sherine Ganem dos Santos	Observational	Not yet recruiting	SARS CoV 2 Infection, RSV Infections, Influenza Infection	150		clinicaltrials.gov
June 11, 2026	NCT07640841	Health Economic Evaluation of Influenza and Pneumococcal Vaccination in COPD Patients	Jiangsu Province Centers for Disease Control and Prevention	Phase 4	Not yet recruiting	Influenza and Pneumonia	7,000		clinicaltrials.gov
June 8, 2026	NCT07633366	BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics	Medical University of Vienna	Observational	Recruiting	ARDS (Acute Respiratory Distress Syndrome)	130	Austria	clinicaltrials.gov
June 8, 2026	NCT07633288	A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With...	SynAct Pharma Aps	Phase 2	Recruiting	Respiratory Viral Infection	96	Bosnia and Herzegovina, Montenegro, New Zealand, Serbia	clinicaltrials.gov
June 4, 2026	NCT07626437	Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common...	Brainfarma Industria Química e Farmacêutica S/A	Phase 3	Recruiting	Common Cold/Flu, Nasal Congestion, Nasal Obstruction	620	Brazil	clinicaltrials.gov
June 1, 2026	NCT07617376	Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions	Wroclaw Medical University	Phase 4	Recruiting	Myocardial Infarction, Decompensated Chronic Heart Failure, Acute Heart Failure (AHF), Pulmonary Embolism Acute...	400	Poland	clinicaltrials.gov
May 28, 2026	NCT07610967	Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections	David Moss	Not applicable	Recruiting	COVID-19 Respiratory Infection, Influenza	130	United States	clinicaltrials.gov
May 22, 2026	NCT07604103	Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute...	University of Brawijaya	Phase 3	Recruiting	Acute Coronary Syndromes (ACS), Pneumonia, COPD (Chronic Obstructive Pulmonary Disease)	60	Indonesia	clinicaltrials.gov
May 22, 2026	NCT07601126	Respiratory Pathogen Distribution During and After the COVID-19 Pandemic	Hisar Intercontinental Hospital	Observational	Completed	Viral Respiratory Infection (e.g., Influenza), Bacterial Respiratory Infections	537	Turkey (Türkiye)	clinicaltrials.gov
May 20, 2026	NCT07599449	Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France	Institut National de la Santé Et de la Recherche Médicale, France	Observational	Recruiting	Respiratory Tract Infections (RTI), Influenza -Like Illness, Influenza, COVID - 19, RSV Infections, Rhinovirus...	25,000	France	clinicaltrials.gov
May 14, 2026	NCT07587801	Vaccination Response Modulation With a Targeted Rapamycin Protocol Study	Central Adelaide Local Health Network Incorporated	Phase 2	Not yet recruiting	Vaccine Immune Response, Haemodialysis Patients, Older Adults	60	Australia	clinicaltrials.gov
April 22, 2026	NCT07545564	A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine	Changchun BCHT Biotechnology Co.	Phase 4	Enrolling by invitation	Influenza	200	China	clinicaltrials.gov
April 13, 2026	NCT07526506	Study of TRX-100 Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers	Traws Pharma, Inc.	Phase 1	Recruiting	Healthy Volunteer	32	Australia	clinicaltrials.gov
April 8, 2026	NCT07516977	Noseguard for Prevention of Respiratory Infections in Real-World Use	Daewoong Pharmaceutical Co. LTD.	Not applicable	Not yet recruiting	Respiratory Infection Virus, COVID-19, Influenza	2,000	South Korea	clinicaltrials.gov
April 8, 2026	NCT07516418	Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age	Sanofi	Phase 1	Recruiting	Respiratory Syncytial Virus (RSV), Influenza A(H5N1)	570	Australia	clinicaltrials.gov
April 2, 2026	NCT07508189	Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho	Can Tho University of Medicine and Pharmacy	Not applicable	Completed	Influenza, Vaccination Coverage, Health Communication	1,237	Vietnam	clinicaltrials.gov
March 31, 2026	NCT07503405	Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model	Traws Pharma, Inc.	Phase 2	Not yet recruiting	Influenza	165	United Kingdom	clinicaltrials.gov
March 27, 2026	NCT07496736	Post-exposure Influenza Prophylaxis in a Hospital Setting	University Medical Centre Ljubljana	Phase 3	Active not recruiting	Influenza	200	Slovenia	clinicaltrials.gov
March 27, 2026	NCT07496450	A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults	ModernaTX, Inc.	Phase 3	Active not recruiting	Influenza	4,050	United Kingdom, United States	clinicaltrials.gov
March 20, 2026	NCT07485855	Influenza Vaccination Strategy for Patients With Hematologic Malignancy	Asan Medical Center	Phase 3	Recruiting	Hematologic Neoplasms, Influenza, Immunogenicity	120	South Korea	clinicaltrials.gov
March 11, 2026	NCT07464314	A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults	GlaxoSmithKline	Phase 1	Recruiting	Influenza, Human+COVID-19	225	United States	clinicaltrials.gov
February 25, 2026	NCT07431853	A Study to Learn About mRNA Vaccines Against Influenza in Adults	Pfizer	Phase 2	Recruiting	Healthy Adults	770	United States	clinicaltrials.gov
February 25, 2026	NCT07431840	Immune Defense Protein Impact On Respiratory Immune Outcomes	Quantec Ltd	Not applicable	Recruiting	Upper Respiratory Disease, Influenza, Viral Upper Respiratory Infection	300	United States	clinicaltrials.gov
February 19, 2026	NCT07421050	Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older	Ab&B Bio-tech Co., Ltd.JS	Phase 1	Active not recruiting	Influenza, Influenza Vaccine	80	China	clinicaltrials.gov
February 19, 2026	NCT07421037	Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older	Ab&B Bio-tech Co., Ltd.JS	Phase 1	Active not recruiting	Influenza, Influenza Vaccine	80	China	clinicaltrials.gov
February 19, 2026	NCT07420985	Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects...	Valenta Pharm JSC	Phase 2	Recruiting	Influenza, Acute Respiratory Viral Infection	300	Russia	clinicaltrials.gov
February 18, 2026	NCT07416266	Lower Respiratory Tract Infections Managed in Primary Care in France	Hôpital Raymond Poincaré	Observational	Completed	Lower Respiratory Tract Infections, Community Acquired Pneumonia (CAP), Acute Bronchitis, Acute Exacerbation Chronic...	230,066		clinicaltrials.gov
February 6, 2026	NCT07393685	Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD	Tianjin Medical University	Observational	Not yet recruiting	Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Influenza, Human, Virus Diseases	300	China	clinicaltrials.gov
January 28, 2026	NCT07372950	Kaiser Colorado Flu Nudge	Kaiser Permanente	Not applicable	Active not recruiting	Influenza, Vaccination	100,000	United States	clinicaltrials.gov
January 28, 2026	NCT07371650	This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate...	Traws Pharma, Inc.	Phase 2	Active not recruiting	Influenza	105	Australia	clinicaltrials.gov
January 22, 2026	NCT07359287	Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care	University Hospital, Caen	Not applicable	Recruiting	Angina, Acute Bronchiolitis, Acute Bronchitis, COPD Exacerbation (AECOPD), Laryngitis, Acute Otitis Media (AOM), Serous...	4,500	France	clinicaltrials.gov
January 22, 2026	NCT07357467	Effect of Oral Supplement on Influenza Vaccine Long-term Response	Tsinghua University	Observational	Not yet recruiting	Influenza, Immunosenescence	30	China	clinicaltrials.gov
January 20, 2026	NCT07351500	Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults	Qingyuan Zhan	Phase 3	Not yet recruiting	Influenza	496		clinicaltrials.gov
January 16, 2026	NCT07349017	A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant)	Changchun BCHT Biotechnology Co.	Phase 1	Not yet recruiting	Influenza	160		clinicaltrials.gov
January 15, 2026	NCT07342556	Evaluating Modes of Influenza Transmission 2b Baseline SAR	University of Maryland, College Park	Not applicable	Not yet recruiting	Influenza (Healthy Volunteers)	80	United States	clinicaltrials.gov
January 14, 2026	NCT07340047	H1ssF Flu Vaccine Clinical Trial	University of Minnesota	Phase 1	Withdrawn	Influenza	0		clinicaltrials.gov
January 12, 2026	NCT07332689	Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older	Ab&B Bio-tech Co., Ltd.JS	Observational	Completed	Influenza Vaccine	42,881	China	clinicaltrials.gov
January 8, 2026	NCT07327398	Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above	Shanghai Institute Of Biological Products	Phase 2	Not yet recruiting	Influenza	1,200	China	clinicaltrials.gov
January 2, 2026	NCT07314905	Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)	Unity Health Toronto	Phase 3	Recruiting	Influenza A, Influenza B, SAR-CoV-2, Acute Respiratory Infections (ARIs)	264	Canada	clinicaltrials.gov
January 2, 2026	NCT07314593	Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults.	Landspitali University Hospital	Not applicable	Recruiting	Respiratory Infections	400	Iceland	clinicaltrials.gov
December 30, 2025	NCT07310472	Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility	Turku University Hospital	Not applicable	Recruiting	Influenza Vaccination	6,000	Finland	clinicaltrials.gov
December 26, 2025	NCT07305207	Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness	Dalhousie University	Phase 1	Recruiting	Influenza (Healthy Volunteers)	32	Canada	clinicaltrials.gov
December 24, 2025	NCT07302256	A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above	Shanghai Institute Of Biological Products	Phase 1	Recruiting	Influenza	120	China	clinicaltrials.gov
December 23, 2025	NCT07300085	A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007)	Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 1	Recruiting	Healthy Participants	710	United States	clinicaltrials.gov
December 18, 2025	NCT07291635	Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine	Aramis Biotechnologies Inc.	Phase 1/2	Active not recruiting	Influenza	728	Canada	clinicaltrials.gov
December 17, 2025	NCT07287137	Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study	Henry M. Jackson Foundation for the Advancement of Military Medicine	Phase 4	Recruiting	COVID -19, COVID - 19, COVID 19, Influenza, Respiratory Virus, Respiratory Viruses, Respiratory Virus Infection...	54	United States	clinicaltrials.gov
December 15, 2025	NCT07282795	Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe	Sanofi	Observational	Recruiting	Influenza Immunization, Healthy Volunteers	670	South Korea	clinicaltrials.gov
November 28, 2025	NCT07254052	Effectiveness of Ammonium Chloride in Reducing Viral Load	National and Kapodistrian University of Athens	Observational	Completed	RNA Virus Infections, Viral Infection COVID-19, Influenza A and B	32	Greece	clinicaltrials.gov
November 25, 2025	NCT07248319	Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases...	Lebanese American University	Not applicable	Not yet recruiting	Produce and Evaluate an Evidence-based Health Awareness Video	160	Lebanon	clinicaltrials.gov
November 21, 2025	NCT07240922	The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study	The University of Hong Kong	Phase 4	Active not recruiting	Influenza	600	Hong Kong	clinicaltrials.gov
November 21, 2025	NCT07240558	Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)	University Health Network, Toronto	Phase 3	Active not recruiting	Influenza (Pandemic), Avian Influenza, Vaccination	120	Canada	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Sanofi	9	October 22, 2026
National Institute of Allergy and Infectious Diseases (NIAID)	7	July 14, 2026
ModernaTX, Inc.	5	October 20, 2026
Ab&B Bio-tech Co., Ltd.JS	5	October 2, 2026
GlaxoSmithKline	5	October 1, 2026
Capital Medical University	4	October 26, 2026
Washington University School of Medicine	3	November 3, 2026
Sinovac Biotech Co., Ltd	3	September 21, 2026
Emory University	3	September 11, 2026
Valenta Pharm JSC	3	June 12, 2026
Traws Pharma, Inc.	3	April 13, 2026
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	3	December 23, 2025
Sanofi Pasteur, a Sanofi Company	3	January 30, 2025
Fudan University	2	October 14, 2026
Korea University Guro Hospital	2	September 24, 2026
Hoffmann-La Roche	2	September 18, 2026
National Taiwan University Hospital	2	June 12, 2026
Jiangsu Province Centers for Disease Control and Prevention	2	June 11, 2026
Wroclaw Medical University	2	June 1, 2026
Changchun BCHT Biotechnology Co.	2	April 22, 2026

By phase

Phase	New trials	Latest
Not applicable	39	October 28, 2026
Observational	29	October 20, 2026
Phase 4	25	November 3, 2026
Phase 1	23	October 13, 2026
Phase 3	22	October 22, 2026
Phase 2	16	November 9, 2026
Phase 1/2	10	August 21, 2026
Phase 2/3	2	October 26, 2026
Early phase 1	2	October 14, 2026

By country

Country	New trials	Latest
United States	55	November 3, 2026
China	26	October 28, 2026
South Korea	9	November 9, 2026
Australia	9	October 14, 2026
France	6	October 20, 2026
Canada	6	July 31, 2026
United Kingdom	5	March 31, 2026
Taiwan	4	September 29, 2026
Japan	3	July 31, 2026
Germany	3	July 23, 2026
Russia	3	June 12, 2026
Belgium	3	October 3, 2025
South Africa	2	October 6, 2026
Spain	2	August 27, 2026
Israel	2	August 17, 2026
Poland	2	June 1, 2026
Hong Kong	2	November 21, 2025
Switzerland	2	December 20, 2024
Singapore	1	October 20, 2026
Denmark	1	August 27, 2026
Austria	1	June 8, 2026
Bosnia and Herzegovina	1	June 8, 2026
Montenegro	1	June 8, 2026
New Zealand	1	June 8, 2026
Serbia	1	June 8, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.